TMIS | Evolocumab + Dr. Haussler
This month in science…
We learned that evolocumab, a monoclonal antibody inhibiting proprotein convertase subtilisin-kexin type 9 (PCSK9), reduces low-density lipoprotein (LDL) cholesterol levels.
Read Morefaculty
Improving pediatric cancer care disparities
In 2007, the 5-year survival rate for children with acute leukemia in Baja California, Mexico was estimated at 10% (vs. 88% in the United States).
Read More
Undifferentiated
Welcome to the Class of 2019! I am thrilled to have this opportunity to be a contributor the COM – P student newspaper, The…
Read More